Propylnorapomorphine

Propylnorapomorphine is a synthetic compound that belongs to the class of dopamine receptor agonists. It is structurally related to apomorphine, a well-known dopamine agonist used in the treatment of Parkinson's disease. Propylnorapomorphine is primarily of interest in research settings for its potential effects on the central nervous system.
Chemical Structure[edit]
Propylnorapomorphine is a derivative of apomorphine, with a propyl group attached to the nitrogen atom of the apomorphine structure. This modification alters its pharmacological properties, potentially affecting its affinity and selectivity for different dopamine receptor subtypes.
Pharmacology[edit]
Propylnorapomorphine acts as an agonist at dopamine receptors, particularly the D2 and D3 subtypes. These receptors are involved in the regulation of motor control, reward, and several other neurological processes. The compound's ability to activate these receptors makes it a subject of interest in the study of neurodegenerative disorders and psychiatric disorders.
Potential Applications[edit]
While not used clinically, propylnorapomorphine is utilized in research to explore the role of dopamine receptors in various physiological and pathological processes. It may help in understanding the mechanisms underlying diseases such as Parkinson's disease, schizophrenia, and addiction.
Synthesis[edit]
The synthesis of propylnorapomorphine involves the chemical modification of apomorphine. This process typically includes the introduction of a propyl group to the nitrogen atom, which can be achieved through various organic synthesis techniques.
Related Compounds[edit]
Propylnorapomorphine is part of a broader class of compounds known as dopaminergic agents. Other related compounds include:
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian